August 04, 2015
ZUBSOLV® Market Access Update on Agreement with CVS Caremark and Announcement of New Exclusive Agreement in Managed Medicaid
Media
August 03, 2015
Cortendo Announces Plans to Redomicile the Cortendo Group’s Parent Company from Sweden to Ireland By Means of an Exchange Offer
July 28, 2015
Q2 2015 General Market Overview
July 27, 2015
Vaxin First-in-Man Phase I Clinical Trial Initiated in Chronically Infected Hepatitis B Patients
July 23, 2015
GenSight Biologics Closes $36 Million Series B Preferred Stock Financing
July 21, 2015
VAXIN STRENGTHENS INTELLECTUAL PROPERTY PORTFOLIO
July 20, 2015
Cortendo Announces Plans to Conduct Registered Initial Public Offering of Its Common Shares
July 15, 2015
Cerenis Therapeutics announces the results of the LOCATION study
July 10, 2015
Completion of NOK 200 million private placement
July 10, 2015
Orexo Interim report January-June 2015
